Collaborations & Alliances

Plasticell, Anthony Nolan Enter Clinical Pact

Aims to advance clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Plasticell will collaborate with research organization Anthony Nolan to advance clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product. Allogeneic haematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with life-threating haematological disorders. Cord blood (CB) is an ideal starting point for allogeneic HSCT as it can be collected and banked without compromising the donor and is more easily matched to recipients re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters